Can low-dose aspirin help prevent heart attacks and stroke in diabetes?
A new study brings hope to people with type 2 diabetes who are at higher risk for heart problems.
It found that taking low-dose aspirin...
This diabetes drug cuts heart attack and stroke risk, study finds
A new international study has found that the diabetes drug albiglutide may help protect people with type 2 diabetes from serious heart problems like...
Could a common diabetes drug boost lifespan in older people?
Researchers at Stanford University and other institutions have found that metformin, a common drug used for type 2 diabetes, might have benefits beyond just...
Is coffee good or bad for diabetes? here’s what you need to know
For many people, a new day doesn’t feel like it’s truly started until they have their first cup of coffee. But if you have...
This drug can prevent heart disease in people with diabetes
A new study has found that a diabetes drug called tirzepatide may be just as effective as another drug, dulaglutide, in protecting the heart...
Low blood sugar can damage your eyes
A new study funded by the U.S. National Institutes of Health has found that low blood sugar, also known as hypoglycemia, may harm the...
Cholesterol drug statins could lower death risk effectively in type 2 diabetes
A large study has found that cholesterol-lowering drugs called statins can help people with type 2 diabetes live longer and avoid major heart problems—even...
Could a new gut treatment replace insulin for people with type 2 diabetes?
More than 37 million people in the United States have diabetes, and most of them have type 2 diabetes. This used to be a...
This smarter Mediterranean diet can cut diabetes risk by 31%
Type 2 diabetes is one of the biggest health problems in the world. It now affects over 530 million people globally, and that number...
This high-sugar fruit can actually reduce diabetes risk
If you had to choose between two snacks—one with just seven grams of sugar and another with over 30 grams—you’d probably assume the lower...









